Target intelligence / Profile preview

Long intergenic non-protein coding RNA 706 (LINC00706)

Target
LINC00706
Molecular classification
Long non-coding RNA (lncRNA), Non-protein coding RNA, Intergenic lncRNA
01

Overview

Long intergenic non-protein coding RNA 706 (LINC00706) is a human long non-coding RNA gene that does not code for a protein, instead functioning as a regulatory RNA. LINC00706 is classified as an intergenic lncRNA, meaning it is transcribed from a region of the genome not overlapping protein-coding genes and greater than 200 nucleotides in length. Although its specific biological role has not been comprehensively defined, lincRNAs as a group have been implicated in regulation of gene expression, chromatin states, and cellular phenotypes such as cell cycle, survival, or immune response, particularly in cancer contexts. Some studies report that LINC00706 is differentially expressed in cancer tissues and can be part of RNA panels associated with immune infiltration or cancer prognosis, but there is no evidence that it functions as a classic drug target, nor that any therapeutic drugs act upon it or use it directly for patient selection. Its clinical significance and molecular mechanism await further elucidation. There is no evidence in the literature or gene databases that LINC00706 is a "therapeutic target" in the traditional sense (e.g., receptor, enzyme, transporter). No drugs are known to directly interact with it, nor are mechanisms of action or safety concerns reported for targeting LINC00706 directly. Most of the available data are descriptive or from bioinformatic/profiling studies, not functional studies indicating a critical disease-driving or "targetable" role.

Other names
LINC00706Long intergenic non-protein coding RNA 706ENSG00000281186 (Ensembl)100652997 (NCBI Gene)GC10U901600 (GeneCards previous ID)GC10M006816 (GeneCards previous ID)
02

Biological functions

Likely involved in gene regulation at the RNA levelPotential roles in chromatin modification and transcript stability (by analogy to other lincRNAs)May contribute to cell differentiation and cell signaling pathways, particularly in cancer (supported generally for lincRNAs, not LINC00706 specifically)
03

Disease associations

Potential biomarker or regulatory molecule in cancerMentioned in molecular immuno-oncology studies as included in gene signatures for immune infiltration subtypesNo direct evidence for a causal, disease-driving role
04

Biomarkers

Included in published gene signatures for cancer patient stratification and immune infiltration (nominal, not clinical use)

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 706 (LINC00706).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 706 (LINC00706).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call